Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Clinical and Economic Outcomes Associated With Exenatide Versus Basal Insulin in People With Type 2 Diabetes

NCT02987348 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02987348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02987348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Clinical and Economic Outcomes Associated With Exenatide Versus Basal Insulin in People With Type 2 Diabetes
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
June 30, 2015
Enrollment
18,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes